Source: PMC Blog

PMC Blog Accelerating Personalization in Cancer Treatment: A Patient's Perspective

by Brad Power, Process Innovator and Cancer Treatment Re-engineer; diagnosed with lymphoma in July of 2018 Summary: The potential of next-generation sequencing to revolutionize cancer treatment by enabling personalized therapies is still more promise than reality. Despite the best intentions ... Continue reading →

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Amy Nicole Nayar's photo - President & CEO of PMC

President & CEO

Amy Nicole Nayar

CEO Approval Rating

82/100

Read more